The top 5 players in the Lisinopril space

April 4, 2022
5min read
Lisinopril
image of chemical makeup of Lisinopril
image of soccer player holding a ball

Innovation activity in the Lisinopril market has been, as a whole, growing over the last 5 years, with a 25.87% average growth rate. The highest annual increase came in 2018 when MSD filed 6 new patents within the space.

The 369 technologies are being applied within 10 different categories, the fastest growing of which is Biochemistry with a 53.33% increase in new patents filed over the past 5 years. The category “Medical” is seeing a lot of filings by new entrants, so it might be an emerging space worth looking into.

For deeper insights on the pharmaceutical industry or another area of focus, visit ipcypris.com and get started using the innovation dashboard and custom reports.

Similar insights you might enjoy

Patent Activity in Next-Gen Photovoltaics: Who's Building the IP Moat

The perovskite photovoltaic patent landscape is consolidating rapidly as LONGi, Oxford PV, and major Chinese manufacturers build IP portfolios spanning device architectures, deposition methods, passivation chemistries, and module-level packaging. Oxford PV's landmark licensing deal with Trina Solar confirms that perovskite patents have crossed from theoretical value to commercially monetizable assets, while GCL's commissioning of the world's first gigawatt-scale perovskite factory signals that manufacturing investment is now following the IP. For corporate R&D teams in advanced materials and chemicals, significant white space remains in enabling materials like encapsulants, barrier films, conductive pastes, and precursor chemistries, but the window for establishing foundational positions is narrowing fast.

Patent Activity in Next-Gen Photovoltaics: Who's Building the IP Moat

The perovskite photovoltaic patent landscape is consolidating rapidly as LONGi, Oxford PV, and major Chinese manufacturers build IP portfolios spanning device architectures, deposition methods, passivation chemistries, and module-level packaging. Oxford PV's landmark licensing deal with Trina Solar confirms that perovskite patents have crossed from theoretical value to commercially monetizable assets, while GCL's commissioning of the world's first gigawatt-scale perovskite factory signals that manufacturing investment is now following the IP. For corporate R&D teams in advanced materials and chemicals, significant white space remains in enabling materials like encapsulants, barrier films, conductive pastes, and precursor chemistries, but the window for establishing foundational positions is narrowing fast.

AI Scientific Literature Review Software for R&D Teams in 2026: Complete Enterprise Guide

AI scientific literature review software helps researchers discover and analyze academic publications using artificial intelligence. The market divides between academic tools serving students and professors, including Semantic Scholar, Elicit, Consensus, and Research Rabbit, and enterprise platforms serving corporate R&D teams. Academic tools focus on paper discovery and citation management with free or low-cost access but lack patent integration, security certifications, and enterprise collaboration features. Cypris is an enterprise R&D intelligence platform providing unified access to 500+ million patents and 270 million scientific papers with SOC 2 Type II certification, a proprietary R&D ontology for semantic search across technical content, and official API partnerships with OpenAI, Anthropic, and Google. Corporate R&D teams require platforms integrating scientific literature with patent landscape analysis to support technology commercialization decisions, competitive intelligence, and strategic research planning.

AI Scientific Literature Review Software for R&D Teams in 2026: Complete Enterprise Guide

AI scientific literature review software helps researchers discover and analyze academic publications using artificial intelligence. The market divides between academic tools serving students and professors, including Semantic Scholar, Elicit, Consensus, and Research Rabbit, and enterprise platforms serving corporate R&D teams. Academic tools focus on paper discovery and citation management with free or low-cost access but lack patent integration, security certifications, and enterprise collaboration features. Cypris is an enterprise R&D intelligence platform providing unified access to 500+ million patents and 270 million scientific papers with SOC 2 Type II certification, a proprietary R&D ontology for semantic search across technical content, and official API partnerships with OpenAI, Anthropic, and Google. Corporate R&D teams require platforms integrating scientific literature with patent landscape analysis to support technology commercialization decisions, competitive intelligence, and strategic research planning.